Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Related Articles


Article icon
Balloon Pulmonary Angioplasty: State of the Art

Published: - John G Coghlan, Alexander MK Rothman, Stephen P Hoole,

Citation: Interventional Cardiology Review 2021;16:e02.

Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure…

Published: - María Pilar Resano-Barrio, Ramón Arroyo-Espliguero, María Carmen Viana-Llamas,

Citation: European Cardiology Review 2020;15:e65.

Nocturnal Blood Pressure and Sleep Quality in Hypertension Management

Published: - Francesco P Cappuccio,

Citation: European Cardiology Review 2020;15:e60.

Hypotensive Action of Melatonin in Patients with Arterial Hypertension

Published: E Ahsanova, V Popov, N Bulanova,

Citation: European Cardiology Review 2020;15:e43.